CardioMech
CardioMech is a Norwegian based company focused on providing a transcatheter alternative to cardiac surgery for the placement of artificial chords for the mitral valve.
5
Funding Rounds
$52.4m
Money raised
Overview
CardioMech is a Norwegian based company focused on providing a transcatheter alternative to cardiac surgery for the placement of artificial chords for the mitral valve.
- Website:
- Business model: B2B
- Headquarters: Trondheim
- Social accounts: linkedin
Funding
Funding series
Funding Series Analysis
The company CardioMech has raised a total of $38.17m in funding over 5 rounds.
Key Insights:
- CardioMech January 2024 Series A Funding Round: $13m
- CardioMech Funding Round, April 2022: $6.17m
- CardioMech August 2020 Series A Funding Round: $19m
- CardioMech AS funding round, August 2019: $5m
- CardioMech AS funding round, August 2020: $9.2m
CardioMech January 2024 Series A Funding Round
$13m
CardioMech Funding Round, April 2022
$6.17m
CardioMech August 2020 Series A Funding Round
$19m
CardioMech AS funding round, August 2019
$5m
CardioMech AS funding round, August 2020
$9.2m
Industries
CardioMech is active in the following industries: